BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 25115849)

  • 1. The potential of transgenic green microalgae; a robust photobioreactor to produce recombinant therapeutic proteins.
    Akbari F; Eskandani M; Khosroushahi AY
    World J Microbiol Biotechnol; 2014 Nov; 30(11):2783-96. PubMed ID: 25115849
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Strategies for high-level recombinant protein expression in transgenic microalgae: a review.
    Potvin G; Zhang Z
    Biotechnol Adv; 2010; 28(6):910-8. PubMed ID: 20728531
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dunaliella as an attractive candidate for molecular farming.
    Barzegari A; Hejazi MA; Hosseinzadeh N; Eslami S; Mehdizadeh Aghdam E; Hejazi MS
    Mol Biol Rep; 2010 Oct; 37(7):3427-30. PubMed ID: 19943116
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stramenopile microalgae as "green biofactories" for recombinant protein production.
    de Grahl I; Reumann S
    World J Microbiol Biotechnol; 2021 Aug; 37(9):163. PubMed ID: 34453200
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Photosynthetic biomanufacturing in green algae; production of recombinant proteins for industrial, nutritional, and medical uses.
    Rasala BA; Mayfield SP
    Photosynth Res; 2015 Mar; 123(3):227-39. PubMed ID: 24659086
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microalgae as platforms for production of recombinant proteins and valuable compounds: progress and prospects.
    Gong Y; Hu H; Gao Y; Xu X; Gao H
    J Ind Microbiol Biotechnol; 2011 Dec; 38(12):1879-90. PubMed ID: 21882013
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Green biologics: The algal chloroplast as a platform for making biopharmaceuticals.
    Taunt HN; Stoffels L; Purton S
    Bioengineered; 2018 Jan; 9(1):48-54. PubMed ID: 28892417
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative Analysis of Culture Conditions for the Optimization of Carotenoid Production in Several Strains of the Picoeukaryote Ostreococcus.
    Guyon JB; Vergé V; Schatt P; Lozano JC; Liennard M; Bouget FY
    Mar Drugs; 2018 Feb; 16(3):. PubMed ID: 29495580
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potential for green microalgae to produce hydrogen, pharmaceuticals and other high value products in a combined process.
    Skjånes K; Rebours C; Lindblad P
    Crit Rev Biotechnol; 2013 Jun; 33(2):172-215. PubMed ID: 22765907
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Manipulation of the microalgal chloroplast by genetic engineering for biotechnological utilization as a green biofactory.
    Kwon YM; Kim KW; Choi TY; Kim SY; Kim JYH
    World J Microbiol Biotechnol; 2018 Nov; 34(12):183. PubMed ID: 30478596
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Haematococcus as a promising cell factory to produce recombinant pharmaceutical proteins.
    Saei AA; Ghanbari P; Barzegari A
    Mol Biol Rep; 2012 Nov; 39(11):9931-9. PubMed ID: 22733498
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nuclear transformation and functional gene expression in the oleaginous microalga Monoraphidium neglectum.
    Jaeger D; Hübner W; Huser T; Mussgnug JH; Kruse O
    J Biotechnol; 2017 May; 249():10-15. PubMed ID: 28302588
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selection of microalgae for biodiesel production in a scalable outdoor photobioreactor in north China.
    Xia L; Song S; He Q; Yang H; Hu C
    Bioresour Technol; 2014 Dec; 174():274-80. PubMed ID: 25463808
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Perspective for the use of genetic transformants in order to enhance the synthesis of the desired metabolites: Engineering chloroplasts of microalgae for the production of bioactive compounds.
    Johanningmeier U; Fischer D
    Adv Exp Med Biol; 2010; 698():144-51. PubMed ID: 21520709
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An economic assessment of astaxanthin production by large scale cultivation of Haematococcus pluvialis.
    Li J; Zhu D; Niu J; Shen S; Wang G
    Biotechnol Adv; 2011; 29(6):568-74. PubMed ID: 21497650
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The use of mushroom-forming fungi for the production of N-glycosylated therapeutic proteins.
    Berends E; Scholtmeijer K; Wösten HA; Bosch D; Lugones LG
    Trends Microbiol; 2009 Oct; 17(10):439-43. PubMed ID: 19758804
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic manipulation of microalgae for the production of bioproducts.
    Vazquez-Villegas P; Torres-Acosta MA; Garcia-Echauri SA; Aguilar-Yanez JM; Rito-Palomares M; Ruiz-Ruiz F
    Front Biosci (Elite Ed); 2018 Jan; 10(2):254-275. PubMed ID: 28930617
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biomass and lipid induction strategies in microalgae for biofuel production and other applications.
    Alishah Aratboni H; Rafiei N; Garcia-Granados R; Alemzadeh A; Morones-Ramírez JR
    Microb Cell Fact; 2019 Oct; 18(1):178. PubMed ID: 31638987
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Computational fluid dynamics simulation in scaling-up of airlift photobioreactor for astaxanthin production.
    Aslanbay Guler B; Deniz I; Demirel Z; Imamoglu E
    J Biosci Bioeng; 2020 Jan; 129(1):86-92. PubMed ID: 31302007
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Industrial potential of carotenoid pigments from microalgae: Current trends and future prospects.
    Ambati RR; Gogisetty D; Aswathanarayana RG; Ravi S; Bikkina PN; Bo L; Yuepeng S
    Crit Rev Food Sci Nutr; 2019; 59(12):1880-1902. PubMed ID: 29370540
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.